Plasma cell‐free DNA quantification is highly correlated to tumor burden in children with neuroblastoma

To evaluate plasma cell‐free DNA (cfDNA) as a promising biomarker for neuroblastoma (NB) tumor burden. Seventy‐nine eligible patients with newly diagnosed NB were recruited from Beijing Children's Hospital between April 2016 and April 2017. Additionally, from September 2011 to June 2017, 79 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xisi, Wang, Lijun, Su, Yan, Yue, Zhixia, Xing, Tianyu, Zhao, Wen, Zhao, Qian, Duan, Chao, Huang, Cheng, Zhang, Dawei, Jin, Mei, Cheng, Xianfeng, Chen, Shenglan, Liu, Yi, Ma, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051223/
https://www.ncbi.nlm.nih.gov/pubmed/29905010
http://dx.doi.org/10.1002/cam4.1586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051223/
https://www.ncbi.nlm.nih.gov/pubmed/29905010
http://dx.doi.org/10.1002/cam4.1586

Ejemplares similares